Skip to main content
Premium Trial:

Request an Annual Quote

NCI Licenses Agilent's Bioinformatics Platforms

NEW YORK (GenomeWeb News) — The National Cancer Institute has purchased a full site license to Agilent Technologies’ bioinformatics products, Agilent announced today.
 
The NCI will use Agilent's GeneSpring, CGH Analytics, Agilent Chip Analytics, and GeneSpring GT platforms for research and analysis.
 
Financial details were not disclosed.

Filed under

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.